{
    "nctId": "NCT00404495",
    "title": "Phase 2 Single-Arm, Open Label Study Of Irinotecan In Combination With Temozolomide In Children With Recurrent Or Refractory Medulloblastoma And In Children With Newly Diagnosed High-Grade Glioma.",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "or",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Recurrent or refractory medulloblastoma in which current standard treatment approaches have failed"
                    },
                    {
                        "type": "variable",
                        "value": "Newly-diagnosed high-grade glioma (World Health Organization \\[WHO\\] grade 3 or 4)"
                    }
                ]
            },
            {
                "type": "variable",
                "value": "Life expectancy \u2265 3 months"
            },
            {
                "type": "variable",
                "value": "Must have minimum age of 6 Months"
            },
            {
                "type": "variable",
                "value": "Must have maximum age of 18 Years"
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Diagnosis of brainstem glioma"
                            },
                            {
                                "type": "variable",
                                "value": "Concurrent administration of any other anti-tumor therapy"
                            },
                            {
                                "type": "variable",
                                "value": "Pre-existing uncontrolled diarrhea"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Life expectancy \u2265 3 months'), Symbol('Must have maximum age of 18 Years'), Symbol('Must have minimum age of 6 Months'), Or(Symbol('Newly-diagnosed high-grade glioma (World Health Organization \\\\[WHO\\\\] grade 3 or 4)'), Symbol('Recurrent or refractory medulloblastoma in which current standard treatment approaches have failed')), Not(Or(Symbol('Concurrent administration of any other anti-tumor therapy'), Symbol('Diagnosis of brainstem glioma'), Symbol('Pre-existing uncontrolled diarrhea'))))"
}